With Sapphire pumps halting manufacturing next year, we are in search of what others are doing regardless of if you use these particular pumps.

1. What pumps does your hospital/system use for epidurals?
2. Does your epidural pump have the capability for interop with the EMR. We are interested specifically with Cerner, but any would be useful.
3. If you utilize the PCA module (for example with Alaris), what interventions are in place to avoid wrong route administrations?

Thank you in advance for your responses.

Now that we are several years into coming up with risk assessments for hazardous drug handling, and now we even have a new NIOSH list pending, I am wondering where hospitals have settled on hazardous precautions for the preparation and administration of phenytoin and fosphenytoin.

This specific issue may not be clinically significant, but I wanted to inquire if others have developed standards for labeling OTC vitamins with multiple ingredients. We recently encountered a bottle of Vitamin D 10 mcg that had both Vitamin D and calcium listed under the "Supplement Facts" portion of the label. Percentage of RDI was 50% for Vitamin D, and 2% for calcium (25 mg as calcium carbonate). All would have been well, except the front of the label contained Vitamin D with no mention of calcium.

Hello,

Do you allow providers to order insulin in the primary IV?

We allow insulin to be infused via an IV insulin protocol, and a TPN protocol both with monitoring parameters. However, when does adding insulin to the primary IV become an insulin infusion? Is this allowed at other hospitals? If this is allowed, is monitoring required? Please share your thoughts?

Thanks
Dale

Good evening,

We are in the process of evaluating how to incorporate investigational drugs into our smart pump library (Alaris) and would love to learn how others handle this type of infusion.

1. Do you add investigational drugs to your smart pump library?

2. If so, how? Are they incorporated within your general care area profiles with unique naming nomenclature (i.e. IDS___), within an investigational drug profile, or through another mechanism?

Greatly appreciate any and all advice you would be willing to share!

Thanks!

Good afternoon all, (I am sorry for the typo on the other posts)

Hope all is well and Safe. ISMP recommends not putting NMBs on override in ADCs and use kits if possible. Can you please share how did you setup your NMBs kits (if you use them)? what are the contents of each kit? where do you store them? are they on override? who have access to them (only anesthesia or there is no restriction)

Thank you so much for your help and insight.

Sincerely,
Mohamed Sarg

Good morning all,

ISMP recommends not putting NMBs on override in ADCs and use kits if possible. Can you please share how did you setup your NMBs kits (if you use them)? what are the contents of each kit? where do you store them? are they on override? who have access to them (only anesthesia or there is no restriction)

Thank you so much for your help and insight.

Sincerely,
Mohamed Sarg

Good morning all,

ISMP recommends not putting NMBs on override in ADCs and use kits if possible. Can you please share how did you setup your NMBs kits (if you use them)? what are the contents of each kit? where do you store them? are they on override? who have access to them (only anesthesia or there is no restriction)

Thank you so much for your help and insight.

Sincerely,
Mohamed Sarg

Good Morning,

Does anyone have guidelines or references on medication administration via central or peripheral line?

With the shortage on dopamine 400mg/500ml which we standardly give peripherally, want to know if it is possible to safely use other concentrations such as 400mg/250ml via this line.

A document with this plus other meds would be helpful to try and devise something at my facility.

Thank you
Hera

Submitting on behalf of a pharmacy student on rotation with me:

Hello,

My name is Kwesi Sefa and I am a 4th year pharmacy student at Shenandoah University. I am currently on my APPE rotations at Johns Hopkins Hospital with the Pediatric Medication Safety officer, Dr. Meghan Rowcliffe.